None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults aged 19 years or older VAS score =40 mm for upper limb pain at the time of consent Experiencing neuropathic pain due to cervical spondylotic myelopathy, with LANSS score =12 History of taking gabapentin or pregabalin for at least one month within 3 months after surgery Willing and able to comply with study procedures and follow-up visits Provided written informed consent after being fully informed about the study
Exclusion criteria
Exclusion criteria: Aged 18 years or younger, or 90 years or older Diagnosed with malignancy and currently undergoing chemotherapy or radiation therapy Diagnosed with and receiving treatment for diabetes mellitus Diagnosed with spinal vascular disorders (e.g., spinal dural arteriovenous malformation) Diagnosed with spinal infectious disease (e.g., spondylitis) Diagnosed with primary or secondary spinal bone tumors Diagnosed with spinal cord tumors Receiving only conservative treatment without surgery More than 3 months have passed since cervical spine surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable is the change in upper limb pain measured by the Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in neuropathic pain: Korean neuropathic pain questionnaire, Leeds assessment of neuropathic symptoms and signs, Pain DETECT Questionnaire;Changes in neurological function: Modified Japanese Orthopaedic Association scale, Neck Disability Index;Pain assessment: visual analogue scale for neck pain, Short-form McGill Pain Questionnaire;Quality of life assessment: EuroQoL 5 Dimension, Short Form 36 health survey | — |
Countries
Korea, Republic of
Contacts
Public ContactPark Danbi
Asan Medical Center
Outcome results
None listed